文献速递免疫规划卫生政策与健康促进

成人流感与新冠多组分联合疫苗策略综述

Multicomponent vaccination against seasonal influenza and COVID-19: a strategy to address the continued global burden of disease in adults.
PubMed 文献 · Vaccine · 2026-09-25

本文综述了针对季节性流感和COVID-19的多组分联合疫苗接种策略的证据。WHO建议在流行病学合理时同时接种流感疫苗和COVID-19疫苗,而多组分联合疫苗方法有可能简化接种流程、减少漏种机会并提高高危人群的疫苗覆盖率。综述总结了多组分疫苗的潜在公共卫生影响、相关挑战以及正在研发的候选疫苗。

要点

  • WHO建议在流行病学合理时同时接种流感疫苗和COVID-19疫苗。
  • 多组分联合疫苗可能简化接种流程、提高覆盖率并降低疾病负担和成本。
  • 医护人员和消费者均对联合疫苗表现出较高兴趣和推荐意愿。

核心结论

  • 多组分流感-COVID-19联合疫苗有望成为成人免疫策略的重要进展,增强对两种重要呼吸道病原体的防护。

研究设计与样本

  • 本文为综述,汇总已发表文献中关于多组分疫苗接种策略的潜在公共卫生影响、相关挑战及正在研发的多组分疫苗。

主要发现

  • 多组分疫苗方法可能带来简化接种方案、提高疫苗覆盖率以及降低疾病负担和成本等益处。
  • 医护人员更倾向于联合疫苗而非单独的流感或COVID-19疫苗,并表示很可能向患者推荐。
  • 消费者也表现出强烈兴趣。

关键数值与推荐

  • WHO建议在流行病学合理时同时接种流感疫苗和COVID-19疫苗以改善接种率。
  • 多组分疫苗接种成功的关键考虑因素包括最佳接种时机以及流感和SARS-CoV-2病毒株的适当选择。

临床怎么用

  • 在成人免疫规划中可考虑多组分联合疫苗策略,以减少漏种机会并提高高危人群覆盖率,同时需关注接种时机和毒株选择。

局限性

  • 本文为综述,未报告原始研究的具体样本量、效应量或统计学显著性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Seasonal influenza and SARS-CoV-2 are respiratory viruses that represent a global health concern, causing substantial numbers of hospitalizations and mortality, particularly among high-risk groups, including infants and older adults. Together these associated respiratory diseases and related complications are among the leading causes of morbidity and mortality. Although effective vaccines are available for protection against influenza and COVID-19, vaccine uptake remains below the levels recommended by the World Health Organization (WHO). Increasing vaccination coverage is critical for protecting vulnerable populations and reducing strain on healthcare systems. To improve vaccine uptake, the WHO recommends co-administering influenza and COVID-19 vaccines when epidemiologically justified. A multicomponent vaccine approach in adults could go beyond the current co-administration approach, as it has the potential to streamline delivery, reduce missed vaccination opportunities, and enhance vaccine coverage among individuals at risk. This manuscript reviews the current evidence on multicomponent vaccination for protection against seasonal influenza and COVID-19. We summarize published literature on the potential public health impacts of a multicomponent vaccination approach, discuss associated challenges, and review multicomponent vaccines currently in development. The studies in this review highlight various potential benefits of a multicomponent approach, including simplified dosing, greater vaccination coverage, and reduced disease burden and costs. Healthcare workers expressed a preference for a combination vaccine over standalone influenza or COVID-19 vaccines, indicating a high likelihood of recommending it to patients. Consumers also showed strong interest. For multicomponent vaccination to succeed, key considerations include the optimal timing of administration and appropriate strain selection for both the influenza and SARS-CoV-2 viruses. Promising multicomponent influenza-COVID-19 vaccine candidates currently being evaluated in clinical trials may represent an important advancement in adult immunization strategy, and a meaningful opportunity to strengthen protection against two of the most consequential respiratory pathogens worldwide.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Schaffner W, Gravenstein S, Kissler S, et al. Multicomponent vaccination against seasonal influenza and COVID-19: a strategy to address the continued global burden of disease in adults. Vaccine. 2026. PMID: 42790130. doi:10.1016/j.vaccine.2026.129082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。